41 related articles for article (PubMed ID: 7880176)
1. [Preparation and characteristics of a tritiated derivative of CP-96,345--a nonpeptide antagonist of the substance P receptor with a high specific radioactivity].
Kasheverov IE; Zaĭtsev DA; Utkin IuN; Tsetlin VI
Bioorg Khim; 1994 Nov; 20(11):1162-8. PubMed ID: 7880176
[TBL] [Abstract][Full Text] [Related]
2. Effect of the nonpeptide NK-1 receptor antagonist CP-96,345 on the morphine withdrawal response of guinea-pigs.
Chahl LA; Johnston PA
Regul Pept; 1993 Jul; 46(1-2):373-5. PubMed ID: 7692540
[No Abstract] [Full Text] [Related]
3. The substance P receptor antagonist CP-96,345 interacts with Ca2+ channels.
Schmidt AW; McLean S; Heym J
Eur J Pharmacol; 1992 Sep; 219(3):491-2. PubMed ID: 1385177
[TBL] [Abstract][Full Text] [Related]
4. Two related neurokinin-1 receptor antagonists have overlapping but different binding sites.
Greenfeder S; Cheewatrakoolpong B; Anthes J; Billah M; Egan RW; Brown JE; Murgolo NJ
Bioorg Med Chem; 1998 Feb; 6(2):189-94. PubMed ID: 9547942
[TBL] [Abstract][Full Text] [Related]
5. (+/-)-CP-96,345, an NK1 receptor antagonist, has local anaesthetic-like effects in a mammalian sciatic nerve preparation.
Karlsson U; Näsström J; Berge OG
Regul Pept; 1994 Jun; 52(1):39-46. PubMed ID: 7972930
[TBL] [Abstract][Full Text] [Related]
6. Photoaffinity labeling of the human substance P (neurokinin-1) receptor with [3H2]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist.
MacDonald D; Silberman SC; Lowe JA; Drozda SE; Leeman SE; Boyd ND
Mol Pharmacol; 1996 May; 49(5):808-13. PubMed ID: 8622630
[TBL] [Abstract][Full Text] [Related]
7. Ventilatory responses to hypoxia in rats pretreated with nonpeptide NK1 receptor antagonist CP-96,345.
De Sanctis GT; Green FH; Jiang X; King M; Remmers JE
J Appl Physiol (1985); 1994 Apr; 76(4):1528-32. PubMed ID: 7519186
[TBL] [Abstract][Full Text] [Related]
8. Both extracellular and transmembrane residues contribute to the species selectivity of the neurokinin-1 receptor antagonist WIN 51708.
Sachais BS; Krause JE
Mol Pharmacol; 1994 Jul; 46(1):122-8. PubMed ID: 8058046
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and neurokinin antagonist activity of 2-benzylidene- and 2-benzyl-3-benzylamino quinuclidines.
Caliendo G; Greco G; Perissutti E; Santagada V; Silipo C; Vittoria A; Turbanti L; Renzetti AR; Benedetti E; Pedone C
Farmaco; 1993 Oct; 48(10):1359-78. PubMed ID: 8117379
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of NK1 antagonists derived from L-tryptophan.
MacLeod AM; Cascieri MA; Merchant KJ; Sadowski S; Hardwicke S; Lewis RT; MacIntyre DE; Metzger JM; Fong TM; Shepheard S
J Med Chem; 1995 Mar; 38(6):934-41. PubMed ID: 7535362
[TBL] [Abstract][Full Text] [Related]
11. Non-specific activity of (+/-)CP-96,345 in models of pain and inflammation.
Nagahisa A; Asai R; Kanai Y; Murase A; Tsuchiya-Nakagaki M; Nakagaki T; Shieh TC; Taniguchi K
Regul Pept; 1993 Jul; 46(1-2):433-6. PubMed ID: 7692559
[No Abstract] [Full Text] [Related]
12. Synthesis, in vitro binding profile, and autoradiographic analysis of [3H]-cis-3-[(2-methoxybenzyl)amino]-2-phenylpiperidine, a highly potent and selective nonpeptide substance P receptor antagonist radioligand.
Rosen T; Seeger TF; McLean S; Desai MC; Guarino KJ; Bryce D; Pratt K; Heym J; Chalabi PM; Windels JH
J Med Chem; 1993 Oct; 36(21):3197-201. PubMed ID: 7693945
[TBL] [Abstract][Full Text] [Related]
13. Tachykinins, via NK1 receptor activation, play a relevant role in plasma protein extravasation evoked by allergen challenge in the airways of sensitized guinea-pigs.
Bertrand C; Geppetti P; Baker J; Yamawaki I; Nadel JA
Regul Pept; 1993 Jul; 46(1-2):214-6. PubMed ID: 7692494
[No Abstract] [Full Text] [Related]
14. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.
Jensen CJ; Gerard NP; Schwartz TW; Gether U
Mol Pharmacol; 1994 Feb; 45(2):294-9. PubMed ID: 7509441
[TBL] [Abstract][Full Text] [Related]
15. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a nonpeptide carbon-11 labeled substance P antagonist for PET studies.
Del Rosario RB; Mangner TJ; Gildersleeve DL; Shreve PD; Weiland DM; Lowe JA; Drozda SE; Snider RM
Nucl Med Biol; 1993 May; 20(4):545-7. PubMed ID: 7684941
[TBL] [Abstract][Full Text] [Related]
17. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888.
Miyayasu K; Mak JC; Nishikawa M; Barnes PJ
Mol Pharmacol; 1993 Sep; 44(3):539-44. PubMed ID: 7690449
[TBL] [Abstract][Full Text] [Related]
18. A selective and potent antagonist of substance P receptors on pancreatic acinar cells.
Sjödin L; Gylfe E
Biochem Int; 1992 Jun; 27(1):145-53. PubMed ID: 1378274
[TBL] [Abstract][Full Text] [Related]
19. Differential blockade by tachykinin NK1 and NK2 receptor antagonists of bronchoconstriction induced by direct-acting agonists and the indirect-acting mimetics capsaicin, serotonin and 2-methyl-serotonin in the anesthetized guinea pig.
Buckner CK; Liberati N; Dea D; Lengel D; Stinson-Fisher C; Campbell J; Miller S; Shenvi A; Krell RD
J Pharmacol Exp Ther; 1993 Dec; 267(3):1168-75. PubMed ID: 8263778
[TBL] [Abstract][Full Text] [Related]
20. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
